Short‐term Outcome in the First 10 Morbidly Obese Adolescent Patients in the FDA‐approved Trial for Laparoscopic Adjustable Gastric Banding

Abstract

At short-term follow-up, weight loss occurred with minimal complications, leading to early resolution of major obesity-related comorbidities. Continued evaluation of the long-term safety and efficacy of LAGB as a surgical adjunct to a comprehensive obesity treatment program is warranted.